Albumin‐Bilirubin Score as a Novel Prognostic Prediction Tool for Surgically Treated Head and Neck Squamous Cell Carcinoma
The Kaohsiung Journal of Medical Sciences · 2025
DOI: 10.1002/kjm2.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Ming-Hsien Tsai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Bilirubin, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Serum Albumin. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Medical Foundation.
Abstract (Originalsprache)
We investigated the prognostic significance of the preoperative albumin‐bilirubin (ALBI) score in surgically treated head and neck squamous cell carcinoma (HNSCC). This retrospective study included 663 patients who underwent radical surgery between 2007 and 2017. The ALBI score, calculated using preoperative bilirubin and albumin levels, was assessed for its impact on overall survival (OS) through univariate and multivariate Cox regression analyses. Patients were randomly assigned to training and validation cohorts in a 3:1 ratio, and using a cutoff of −2.871, patients were stratified into low‐ and high‐ALBI groups, revealing significant prognostic differences in both cohorts. A high preoperative ALBI score was an independent predictor of worse OS in both cohorts, with an ALBI‐based nomogram being developed to predict OS with strong concordance indices (0.759 and 0.749 in the training and validation cohorts, respectively). Accordingly, the ALBI score is a simple and effective prognostic marker for improving risk stratification and survival prediction in HNSCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- School of Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan.
- School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan.
- Department of Hematology and Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Doctoral Program of Clinical and Experimental Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan.
ORCID-Profile: Ming-Hsien Tsai, Wen-Ling Tsai, Fu-Min Fang
Förderung
- Chang Gung Medical Foundation
Zitieren
APA
Tsai, M. H., Yang, C. H., Lin, Y. T., Chuang, H. C., Huang, T. L., Lu, H., Tsai, W. L., Chien, C. Y., & Fang, F. M. (2025). Albumin‐Bilirubin Score as a Novel Prognostic Prediction Tool for Surgically Treated Head and Neck Squamous Cell Carcinoma. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70115
Vancouver
Tsai MH, Yang CH, Lin YT, Chuang HC, Huang TL, Lu H, et al. Albumin‐Bilirubin Score as a Novel Prognostic Prediction Tool for Surgically Treated Head and Neck Squamous Cell Carcinoma. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70115
BibTeX
@article{Tsai2025,
author = {Tsai, Ming-Hsien and Yang, Chao-Hui and Lin, Yu-Tsai and Chuang, Hui-Ching and Huang, Tai-Lin and Lu, Hui and Tsai, Wen-Ling and Chien, Chih-Yen and Fang, Fu-Min},
title = {Albumin‐Bilirubin Score as a Novel Prognostic Prediction Tool for Surgically Treated Head and Neck Squamous Cell Carcinoma},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2025},
doi = {10.1002/kjm2.70115}
}
EUVIMED